BACKGROUND: In Brazil nationally representative donor data are limited on human immunodeficiency virus (HIV) prevalence, incidence, and residual transfusion risk. The objective of this study was to analyze HIV data obtained over 24 months by the Retrovirus Epidemiology Donor Study-II program in Brazil. STUDY DESIGN AND METHODS: Donations reactive to third- and fourth-generation immunoassays (IAs) were further confirmed by a less-sensitive (LS) IA algorithm and Western blot (WB). Incidence was calculated for first-time (FT) donors using the LS-EIA results and for repeat donors with a model developed to include all donors with a previous negative donation. Residual risk was projected by multiplying composite FT and repeat donor incidence rates by HIV marker-negative infectious window periods. RESULTS: HIV prevalence among FT donors was 92.2/10(5) donations. FT and repeat donor and composite incidences were 38.5 (95% confidence interval [CI], 25.6-51.4), 22.5 (95% CI, 17.6-28.0), and 27.5 (95% CI, 22.0-33.0) per 100,000 person-years, respectively. Male and community donors had higher prevalence and incidence rates than female and replacement donors. The estimated residual risk of HIV transfusion transmission was 11.3 per 10(6) donations (95% CI, 8.4-14.2), which could be reduced to 4.2 per 10(6) donations (95% CI, 3.2-5.2) by use of individual-donation nucleic acid testing (NAT). CONCLUSION: The incidence and residual transfusion risk of HIV infection are relatively high in Brazil. Implementation of NAT will not be sufficient to decrease transmission rates to levels seen in the United States or Europe; therefore, other measures focused on decreasing donations by at-risk individuals are also necessary.
BACKGROUND: In Brazil nationally representative donor data are limited on human immunodeficiency virus (HIV) prevalence, incidence, and residual transfusion risk. The objective of this study was to analyze HIV data obtained over 24 months by the Retrovirus Epidemiology Donor Study-II program in Brazil. STUDY DESIGN AND METHODS: Donations reactive to third- and fourth-generation immunoassays (IAs) were further confirmed by a less-sensitive (LS) IA algorithm and Western blot (WB). Incidence was calculated for first-time (FT) donors using the LS-EIA results and for repeat donors with a model developed to include all donors with a previous negative donation. Residual risk was projected by multiplying composite FT and repeat donor incidence rates by HIV marker-negative infectious window periods. RESULTS:HIV prevalence among FT donors was 92.2/10(5) donations. FT and repeat donor and composite incidences were 38.5 (95% confidence interval [CI], 25.6-51.4), 22.5 (95% CI, 17.6-28.0), and 27.5 (95% CI, 22.0-33.0) per 100,000 person-years, respectively. Male and community donors had higher prevalence and incidence rates than female and replacement donors. The estimated residual risk of HIV transfusion transmission was 11.3 per 10(6) donations (95% CI, 8.4-14.2), which could be reduced to 4.2 per 10(6) donations (95% CI, 3.2-5.2) by use of individual-donation nucleic acid testing (NAT). CONCLUSION: The incidence and residual transfusion risk of HIV infection are relatively high in Brazil. Implementation of NAT will not be sufficient to decrease transmission rates to levels seen in the United States or Europe; therefore, other measures focused on decreasing donations by at-risk individuals are also necessary.
Authors: Michael P Busch; Christopher D Pilcher; Timothy D Mastro; John Kaldor; Gaby Vercauteren; William Rodriguez; Christine Rousseau; Thomas M Rehle; Alex Welte; Megan D Averill; Jesus M Garcia Calleja Journal: AIDS Date: 2010-11-27 Impact factor: 4.177
Authors: S A Glynn; S H Kleinman; G B Schreiber; M P Busch; D J Wright; J W Smith; C C Nass; A E Williams Journal: JAMA Date: 2000-07-12 Impact factor: 56.272
Authors: Ester C Sabino; Nanci A Salles; Cesar de Almeida-Neto; Angela M Barreto; Fernando Basques; Emanuelle A Barros; Alfredo Mendrone; Michael P Busch Journal: Transfusion Date: 2011-01 Impact factor: 3.157
Authors: Thelma T Gonçalez; Ester C Sabino; Nanci Alves Salles; Cesar de Almeida-Neto; Alfredo Mendrone; Pedro E Dorlhiac-Laccer; Jing Liu; Edward L Murphy; George B Schreiber Journal: Transfusion Date: 2009-12-09 Impact factor: 3.157
Authors: C D L Oliveira; T Goncalez; D Wright; P C Rocha; C Miranda; L Capuani; A B Carneiro-Proietti; F A Proietti; C de Almeida-Neto; N M Larsen; D Sampaio; B Custer Journal: Vox Sang Date: 2012-08-15 Impact factor: 2.144
Authors: C Miranda; E Moreno; R Bruhn; N M Larsen; D J Wright; C D L Oliveira; A B F Carneiro-Proietti; P Loureiro; C de Almeida-Neto; B Custer; E C Sabino; T T Gonçalez Journal: Vox Sang Date: 2013-12-09 Impact factor: 2.144
Authors: Thelma T Gonçalez; Ester C Sabino; Karen S Schlumpf; David J Wright; Alfredo Mendrone; Maria Lopes; Silvana Leão; Carolina Miranda; Ligia Capuani; Anna Barbara F Carneiro-Proietti; Fernando Basques; João E Ferreira; Michael Busch; Brian Custer Journal: Transfusion Date: 2012-07-31 Impact factor: 3.157
Authors: Paula Fraiman Blatyta; Brian Custer; Thelma Terezinha Gonçalez; Rebecca Birch; Maria Esther Lopes; Maria Ines Lopes Ferreira; Anna Barbara Carneiro Proietti; Ester Cerdeira Sabino; Kimberly Page; Cesar de Almeida-Neto Journal: Transfusion Date: 2013-03-22 Impact factor: 3.157
Authors: Cesar de Almeida-Neto; Ester Cerdeira Sabino; Jing Liu; Paula Fraiman Blatyta; Alfredo Mendrone-Junior; Nanci Alves Salles; Silvana Carneiro Leão; David J Wright; Fernando Valadares Basques; João Eduardo Ferreira; Michael P Busch; Edward L Murphy Journal: Transfusion Date: 2012-08-06 Impact factor: 3.157
Authors: Cecília S Alencar; Ester C Sabino; Silvia M F Carvalho; Silvana C Leao; Anna B Carneiro-Proietti; Ligia Capuani; Cláudia L Oliveira; Danielle Carrick; Rebecca J Birch; Thelma T Gonçalez; Sheila Keating; Priscilla A Swanson; John Hackett; Michael P Busch Journal: J Acquir Immune Defic Syndr Date: 2013-07-01 Impact factor: 3.731
Authors: Pedro L Takecian; Marcio K Oikawa; Kelly R Braghetto; Paulo Rocha; Fred Lucena; Katherine Kavounis; Karen S Schlumpf; Susan Acker; Anna B F Carneiro-Proietti; Ester C Sabino; Brian Custer; Michael P Busch; João E Ferreira Journal: Decis Support Syst Date: 2013-06-01 Impact factor: 5.795